Similarly, CEA expression has been identified as a biomarker for predicting cancer incidence, especially for gastric cancer and CRC, with the ability to promote tumor migration, invasion, metastasis, and angiogenesis [26–28]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.